DFE Pharma

Abstract The development of dry powder inhalers (DPIs) for pulmonary drug delivery is complex, requiring optimization of variable factors to...

Frankfurt, Germany, 02 October, 2024 The future of excipients is here: Meet DFE Pharma at CPHI DFE Pharma invites you to...

Abstract Oral administration of solid dosage forms for delivery of therapeutic peptides is highly desired. Preclinical investigations on co-administration with...

Abstract Regime maps are vital in twin-screw granulation, predicting outcomes via dimensionless numbers. This study develops a novel regime map...

This year CPHI Europe opens its doors in Frankfurt at Messe Frankfurt. From 28th to 30th October you can have...

Abstract Binding agents play an important role in maintaining the bond between active and additional ingredients in tablets, especially when...

Abstract Mini-tablets of different proportions of α-lactose monohydrate (LAC) and microcrystalline cellulose (MCC) were prepared by uniaxial compaction and served as...

Abstract The development of a robust oral solid dosage form requires knowledge of all the sources of variation that could...

Abstract Nitrosamine impurities have garnered recent attention due to their presence in pharmaceuticals and their mutagenic risks. Recent studies have...

Press Release Goch, Germany - May 7th, 2025 - DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions,...